Skip to content
Disclosery

General Catalyst Group Management, LLC

Follow

13F filer, CIK 1637946, CAMBRIDGE, MA

General Catalyst Group Management, LLC reported $188,517,817 across 14 holdings for the quarter ended 2026-06-30, in a 13F-HR filed 2026-08-17. Its ten largest share positions make up 98.96% of the portfolio.

Filed (acceptance time not in the bulk data set), ingested 13F-HR 0001637946-26-000002

Period
2026-06-30
Reported value
$189M
Holdings
14
Top 10 weight
98.96%
New
4
Sold out
2

Largest buys vs the previous quarter

SecurityShares changeApprox. value
PBLSnew+1,600,937$43.8M
ODTXnew+810,272$15.2M
DASHnew+2,850$526K
CVNAnew+6,465$426K
METAadded+662$373K

Ranked by the share change valued at this quarter's implied price (value over shares in the 13F). A position sold out is valued at the previous quarter's price, its last report.

Largest sells vs the previous quarter

SecurityShares changeApprox. value
IOTexited-2,000,000-$63.4M
GTLBexited-921,405-$19.9M
GUTSreduced-7-$5

Ranked by the share change valued at this quarter's implied price (value over shares in the 13F). A position sold out is valued at the previous quarter's price, its last report.

Holdings, Q2 2026

Share positions as resolved from 13F-HR 0001637946-26-000002, largest first. % of portfolio is the value over $188,517,817, the sum of the share positions whose value is usable for ratios (method).

SecurityHistorySharesValue% of portfolioChangeLatest eventTimeline
AVBPARRIVENT BIOPHARMA INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: 1,494,786 shares; 2024Q4: 1,494,786 shares; 2025Q1: 1,494,786 shares; 2025Q2: 1,494,786 shares; 2025Q3: 1,494,786 shares; 2025Q4: 1,494,786 shares; 2026Q1: 1,494,786 shares; 2026Q2: 1,494,786 shares 1,494,786$51.9M27.55%0Timeline
PBLSPARABILIS MEDICINES INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: 1,600,937 shares 1,600,937$43.8M23.24%newTimeline
CARTMAPLEBEAR INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: 710,711 shares; 2024Q4: 710,711 shares; 2025Q1: 710,711 shares; 2025Q2: 710,711 shares; 2025Q3: 710,711 shares; 2025Q4: 710,711 shares; 2026Q1: 710,711 shares; 2026Q2: 710,711 shares 710,711$33.7M17.85%0Timeline
MAZEMAZE THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: 1,035,910 shares; 2025Q2: 1,035,910 shares; 2025Q3: 1,035,910 shares; 2025Q4: 1,035,910 shares; 2026Q1: 1,035,910 shares; 2026Q2: 1,035,910 shares 1,035,910$30.9M16.4%0Timeline
ODTXODYSSEY THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: 810,272 shares 810,272$15.2M8.04%newTimeline
EIKNEIKON THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: 305,233 shares; 2026Q2: 305,233 shares 305,233$3.98M2.11%0Timeline
GUTSFRACTYL HEALTH INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: 4,884,193 shares; 2025Q3: 4,884,193 shares; 2025Q4: 4,884,193 shares; 2026Q1: 4,884,193 shares; 2026Q2: 4,884,186 shares 4,884,186$3.88M2.06%-7Timeline
LIFEETHOS TECHNOLOGIES INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: 74,179 shares; 2026Q2: 74,179 shares 74,179$1.35M0.71%0Timeline
CPNGCOUPANG INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: 36,677 shares; 2026Q2: 54,677 shares 54,677$950K0.5%+18,000Timeline
AMZNAMAZON COM INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: 2,582 shares; 2026Q2: 3,882 shares 3,882$925K0.49%+1,300Timeline
METAMETA PLATFORMS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: 658 shares; 2026Q2: 1,320 shares 1,320$744K0.39%+662Timeline
DASHDOORDASH INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: 2,850 shares 2,850$526K0.28%newTimeline
CVNACARVANA COQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: 6,465 shares 6,465$426K0.23%newTimeline
FIGFIGMA INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: 877,174 shares; 2025Q4: 14,845 shares; 2026Q1: 14,845 shares; 2026Q2: 14,845 shares 14,845$269K0.14%0Timeline

Sold out in Q2 2026

Positions in the previous quarter's report that this quarter's report no longer lists.

SecurityShares beforeValue beforeType
IOTSAMSARA INC2,000,000$63.4Mshares
GTLBGITLAB INC921,405$19.9Mshares

How Q2 2026 was built

Available 13F filings of this filer for the quarter and their roles: the base report is the latest original or restatement, NEW HOLDINGS amendments filed after it are added (method).

FilingRoleAmendmentFiledAcceptedIngested
13F-HR 0001637946-26-000002 base2026-08-17acceptance time not in the bulk data set

Filings

Every filing of this filer: 13F reports and notices, the 13D and 13G it filed or is a reporting person of, and Forms 3, 4 and 5 it reported as an owner.

FilingSubjectFiledAcceptedIngested
13F-HR 0001637946-26-000002 Quarter ended 2026-06-302026-08-17acceptance time not in the bulk data set
13F-HR 0000905148-26-002373 Quarter ended 2026-03-312026-05-15acceptance time not in the bulk data set
13F-HR 0000905148-26-000847 Quarter ended 2025-12-312026-02-17acceptance time not in the bulk data set
13F-HR 0000905148-25-004012 Quarter ended 2025-09-302025-11-14acceptance time not in the bulk data set
13F-HR 0000905148-25-002968 Quarter ended 2025-06-302025-08-14acceptance time not in the bulk data set
13F-HR 0000950123-25-003553 Quarter ended 2025-03-312025-04-16acceptance time not in the bulk data set
13F-HR 0000950123-25-000524 Quarter ended 2024-12-312025-01-23acceptance time not in the bulk data set
13F-HR 0000950123-24-010430 Quarter ended 2024-09-302024-11-06acceptance time not in the bulk data set
13F-HR 0000950123-24-008434 Quarter ended 2024-06-302024-08-14acceptance time not in the bulk data set
13F-HR 0000950123-24-004302 Quarter ended 2024-03-312024-05-10acceptance time not in the bulk data set
13F-HR 0000950123-24-001201 Quarter ended 2023-12-312024-02-09acceptance time not in the bulk data set
13F-HR 0000950123-23-009820 Quarter ended 2023-09-302023-11-09acceptance time not in the bulk data set
13F-HR 0000950123-23-006784 Quarter ended 2023-06-302023-08-08acceptance time not in the bulk data set
13F-HR 0000950123-23-003250 Quarter ended 2023-03-312023-04-14acceptance time not in the bulk data set
13F-HR 0000950123-23-002767 Quarter ended 2022-12-312023-02-15acceptance time not in the bulk data set
13F-HR 0000950123-22-011252 Quarter ended 2022-09-302022-11-09acceptance time not in the bulk data set
13F-HR 0000950123-22-007518 Quarter ended 2022-06-302022-07-29acceptance time not in the bulk data set
13F-HR 0000950123-22-004605 Quarter ended 2022-03-312022-05-05acceptance time not in the bulk data set
13F-HR 0000950123-22-002761 Quarter ended 2021-12-312022-02-14acceptance time not in the bulk data set
13F-HR 0000950123-21-015605 Quarter ended 2021-09-302021-11-15acceptance time not in the bulk data set
13F-HR 0000950123-21-011348 Quarter ended 2021-06-302021-08-16acceptance time not in the bulk data set
13F-HR 0000950123-21-006499 Quarter ended 2021-03-312021-05-14acceptance time not in the bulk data set
13F-HR 0000950123-21-002945 Quarter ended 2020-12-312021-02-16acceptance time not in the bulk data set
13F-HR 0001012975-18-001206 Quarter ended 2018-09-302018-11-13acceptance time not in the bulk data set
13F-HR 0001012975-18-000948 Quarter ended 2018-06-302018-08-03acceptance time not in the bulk data set
13F-HR 0001012975-18-000366 Quarter ended 2018-03-312018-04-25acceptance time not in the bulk data set
13F-HR 0001012975-18-000149 Quarter ended 2017-12-312018-02-12acceptance time not in the bulk data set